Status:
COMPLETED
The Objective of This Study Was to Compare and Quantify the Bioavailability of Citrulline Byproducts in Blood Samples and in Urine Samples After a Single Dose of the Assigned Dietary Supplement. The Treatment Arms Containing the Following Molecules: Citrulline HCL and L-Citrulline,
Lead Sponsor:
Vireo Systems, Inc.
Collaborating Sponsors:
Princeton Consumer Research
Conditions:
Bioavailability and AUC
Eligibility:
All Genders
18-64 years
Brief Summary
Citrulline dietary supplements are of interest for improving cardiovascular and exercise performance. The health benefits of citrulline are attributable to its ability to increase arginine levels in t...
Eligibility Criteria
Inclusion
- healthy and hydrated male or female ages 18-64; agrees to refrain from citrulline-rich foods; able and willing to fast 12 hours prior to baseline visit; willing to have blood and urine collections as dictated in the protocol; females of child bearing age have some type of birth control.
Exclusion
- female subject is pregnant; allergies or sensitivities to citrulline products; history of losing consciousness during blood collection;past medical history of iron deficiency; history of or current treatment for hypertension, coronary heart disease; or angina pectoris; known kidney function issues or disorders; being treated with ACE inhibitors; cancer diagnosis within 5 years of visit; history of chronic disease.
Key Trial Info
Start Date :
July 13 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 27 2024
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT06977854
Start Date
July 13 2024
End Date
July 27 2024
Last Update
May 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Princeton Consumer Research
Raritan, New Jersey, United States, 08869